EK
EKF Diagnostics Holdings plc
EKDHF · OTC
$0.34 +0.15% (+$0.00)
Market Cap £109.5M
P/E Ratio 51.61x
Div. Yield -
ROE 3.00%
Bulios Fair Price
$0.3
11.9% downside
Current Price
$0.34
Undervalued Fair Value Overvalued
According to Bulios Fair Price, EKDHF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Strong
7/9Valuation
59 /100
Fair P/B 1.59x
P/S 2.12x
P/E 51.61x
Growth
38 /100
Stable FCF growth 28.42%
Book val. growth 2.00%
Rev. growth 8.20%
Profitability
70 /100
Strong FCF margin 15.86%
Op. margin 13.08%
Gross margin 51.35%
Quality
21 /100
Poor Asset turnover 0.64x
ROA 2.62%
ROIC 3.25%
Debt
100 /100
Low Net debt/EBITDA -2.14x
Int. coverage 43.81x
Debt/Equity 0.02x
Stability
52 /100
Moderate Profitable years 3
EPS volatility 123.54%
Beta 0.50x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about EKDHF
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Gavin Joseph Jones
Employees
301
Headquarters
Cardiff
Upcoming events
30 MAR
Earnings
Upcoming earnings report